The difference between GEICO’s costs and those of its competitors is a kind of moat that protects a valuable and ...

The forward-looking outlook also doesn't speak of worsening. Micron expects revenue in fiscal Q1 to come in at approximately ...

Moderna's (MRNA) stock surged on cancer vaccine hype, but analysts warn sales forecasts and valuation are stretched ahead of key trial readouts. Read more here.

Consumer discretionary (XLY) fell 7.8% in Q3. See top winners/losers, key earnings drivers, and what to watch into holiday season—read now.

Micron is positioned for record revenue growth and tighter supply-demand conditions through 2028. Read why MU stock is a Buy.

Kimbell Royalty Partners (KRP) upgraded to Strong Buy: 13% forward yield, record quarter, rising distributions and ...

TSMC outlook: strong Q3 earnings, bullish AI demand, and capex commentary expected. Click for more on TSM stock.

Yen and dollar strength signals shifting liquidity and risk-off sentiment. Read more on the US dollar and Japanese yen and ...

Target and Victoria’s Secret comeback: how new CEOs drove retail turnarounds with focus, cost cuts, digital growth and ...

Oshkosh Corporation is upgraded to a strong buy with a $180.56 price target, driven by a robust balance sheet and multi-year ...

President Donald Trump has named Director of National Intelligence Jay Clayton to lead a new White House artificial ...

Weyerhaeuser (WY) and Rayonier (RYN) look undervalued after share weakness, with attractive dividends and upside potential.